Voisard Asset Management Group »

Iovance Biotherapeutics shares owned by Voisard Asset Management Group

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Voisard Asset Management Group from 13F filings

Historical chart of Voisard Asset Management Group investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Voisard Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Voisard Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.0k 273 14.82
2023-12-31 $2.2k 273 8.13

More positions owned by Voisard Asset Management Group

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exch Trd Slf Idx Bulshs 2024 Cb (BSCO)

View all positions for Voisard Asset Management Group

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Jpmorgan Chase & Co
Balyasny Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Dimensional Fund Advisors
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics